Patrizia Stoitzner

Author PubWeight™ 45.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev 2010 2.44
2 Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells. J Invest Dermatol 2005 1.78
3 Langerhans cells - dendritic cells of the epidermis. APMIS 2003 1.64
4 Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response. Eur J Immunol 2013 1.63
5 Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis. J Invest Dermatol 2004 1.60
6 The dermal microenvironment induces the expression of the alternative activation marker CD301/mMGL in mononuclear phagocytes, independent of IL-4/IL-13 signaling. J Leukoc Biol 2006 1.59
7 The late endosomal adaptor molecule p14 (LAMTOR2) represents a novel regulator of Langerhans cell homeostasis. Blood 2013 1.54
8 Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J Immunol 2002 1.49
9 Ontogeny of Langerin/CD207 expression in the epidermis of mice. J Invest Dermatol 2004 1.41
10 Functional redundancy of Langerhans cells and Langerin+ dermal dendritic cells in contact hypersensitivity. J Invest Dermatol 2010 1.31
11 Expression of C-type lectin receptors by subsets of dendritic cells in human skin. Int Immunol 2004 1.29
12 Expression of XCR1 Characterizes the Batf3-Dependent Lineage of Dendritic Cells Capable of Antigen Cross-Presentation. Front Immunol 2012 1.23
13 Epidermal Langerhans cells--changing views on their function in vivo. Immunol Lett 2006 1.18
14 A model system using tape stripping for characterization of Langerhans cell-precursors in vivo. J Invest Dermatol 2004 1.13
15 Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic cells. J Immunol 2009 1.10
16 Expression of langerin/CD207 reveals dendritic cell heterogeneity between inbred mouse strains. Immunology 2008 1.10
17 Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis. J Invest Dermatol 2009 1.10
18 Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens. J Immunol 2009 1.09
19 Different role of CD73 in leukocyte trafficking via blood and lymph vessels. Blood 2011 1.06
20 Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy. Cancer Immunol Immunother 2008 1.04
21 ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling. Blood 2003 1.03
22 ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells. J Immunol 2011 1.02
23 NK cells are required for dendritic cell-based immunotherapy at the time of tumor challenge. J Immunol 2014 0.99
24 Langerhans cells and dermal dendritic cells capture protein antigens in the skin: possible targets for vaccination through the skin. Immunobiology 2010 0.98
25 Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine. Immunol Cell Biol 2011 0.94
26 Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapy. J Immunol 2009 0.93
27 Adenosine slows migration of dendritic cells but does not affect other aspects of dendritic cell maturation. J Invest Dermatol 2003 0.91
28 Murine melanoma-infiltrating dendritic cells are defective in antigen presenting function regardless of the presence of CD4CD25 regulatory T cells. PLoS One 2011 0.88
29 Skin inflammation is not sufficient to break tolerance induced against a novel antigen. J Immunol 2009 0.88
30 IL-4 supports the generation of a dendritic cell subset from murine bone marrow with altered endocytosis capacity. J Leukoc Biol 2004 0.86
31 Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses. J Immunol 2012 0.86
32 The Langerhans cell controversy: are they immunostimulatory or immunoregulatory cells of the skin immune system? Immunol Cell Biol 2010 0.86
33 Anatomical distribution analysis reveals lack of Langerin+ dermal dendritic cells in footpads and tail of C57BL/6 mice. Exp Dermatol 2014 0.85
34 The lymph vessel network in mouse skin visualised with antibodies against the hyaluronan receptor LYVE-1. Immunobiology 2008 0.84
35 Peroxisome proliferator-activated receptor-alpha activation inhibits Langerhans cell function. J Immunol 2007 0.83
36 Conditioning of the injection site with CpG enhances the migration of adoptively transferred dendritic cells and endogenous CD8+ T-cell responses. J Immunother 2010 0.82
37 The role of the e3 ligase cbl-B in murine dendritic cells. PLoS One 2013 0.79
38 Tetrahydro-4-aminobiopterin attenuates dendritic cell-induced T cell priming independently from inducible nitric oxide synthase. J Immunol 2005 0.79
39 Cytip regulates dendritic-cell function in contact hypersensitivity. Eur J Immunol 2012 0.76
40 Langerhans cells come in waves. Immunity 2012 0.75
41 Development and maturation of Langerhans cells, spleen and bone marrow dendritic cells in TNF-alpha/lymphotoxin-alpha double-deficient mice. Immunol Lett 2005 0.75